Hodgson Ian, Plummer Mary L, Konopka Sarah N, Colvin Christopher J, Jonas Edna, Albertini Jennifer, Amzel Anouk, Fogg Karen P
Independent Consultant, Bingley, United Kingdom.
Independent Consultant, Dar es Salaam, Tanzania.
PLoS One. 2014 Nov 5;9(11):e111421. doi: 10.1371/journal.pone.0111421. eCollection 2014.
Despite progress reducing maternal mortality, HIV-related maternal deaths remain high, accounting, for example, for up to 24 percent of all pregnancy-related deaths in sub-Saharan Africa. Antiretroviral therapy (ART) is effective in improving outcomes among HIV-infected pregnant and postpartum women, yet rates of initiation, adherence, and retention remain low. This systematic literature review synthesized evidence about individual and contextual factors affecting ART use among HIV-infected pregnant and postpartum women.
Searches were conducted for studies addressing the population (HIV-infected pregnant and postpartum women), intervention (ART), and outcomes of interest (initiation, adherence, and retention). Quantitative and qualitative studies published in English since January 2008 were included. Individual and contextual enablers and barriers to ART use were extracted and organized thematically within a framework of individual, interpersonal, community, and structural categories.
Thirty-four studies were included in the review. Individual-level factors included both those within and outside a woman's awareness and control (e.g., commitment to child's health or age). Individual-level barriers included poor understanding of HIV, ART, and prevention of mother-to-child transmission, and difficulty managing practical demands of ART. At an interpersonal level, disclosure to a spouse and spousal involvement in treatment were associated with improved initiation, adherence, and retention. Fear of negative consequences was a barrier to disclosure. At a community level, stigma was a major barrier. Key structural barriers and enablers were related to health system use and engagement, including access to services and health worker attitudes.
To be successful, programs seeking to expand access to and continued use of ART by integrating maternal health and HIV services must identify and address the relevant barriers and enablers in their own context that are described in this review. Further research on this population, including those who drop out of or never access health services, is needed to inform effective implementation.
尽管在降低孕产妇死亡率方面取得了进展,但与艾滋病病毒相关的孕产妇死亡人数仍然居高不下,例如在撒哈拉以南非洲,此类死亡人数占所有与妊娠相关死亡人数的比例高达24%。抗逆转录病毒疗法(ART)在改善感染艾滋病病毒的孕妇和产后妇女的结局方面有效,但治疗的启动率、依从性和持续性仍然很低。本系统文献综述综合了关于影响感染艾滋病病毒的孕妇和产后妇女使用抗逆转录病毒疗法的个体因素和背景因素的证据。
检索了针对研究人群(感染艾滋病病毒的孕妇和产后妇女)、干预措施(抗逆转录病毒疗法)以及感兴趣的结局(治疗启动、依从性和持续性)的研究。纳入了自2008年1月以来以英文发表的定量和定性研究。提取了抗逆转录病毒疗法使用的个体因素和背景因素促成因素及障碍因素,并在个体、人际、社区和结构类别框架内按主题进行了整理。
该综述纳入了34项研究。个体层面的因素包括女性意识到并能控制的因素以及未意识到和无法控制的因素(例如对孩子健康的承诺或年龄)。个体层面的障碍包括对艾滋病病毒、抗逆转录病毒疗法以及母婴传播预防的理解不足,以及应对抗逆转录病毒疗法实际需求的困难。在人际层面,向配偶披露病情以及配偶参与治疗与治疗启动、依从性和持续性的改善相关。对负面后果的恐惧是披露病情的障碍。在社区层面,耻辱感是一个主要障碍。关键的结构障碍和促成因素与卫生系统的使用和参与有关,包括获得服务的机会和医护人员的态度。
为取得成功,旨在通过整合孕产妇保健和艾滋病病毒服务来扩大抗逆转录病毒疗法的可及性并促进其持续使用的项目,必须识别并解决本综述中所描述的、与其自身背景相关的障碍和促成因素。需要对这一人群,包括那些退出或从未获得卫生服务的人群开展进一步研究,以为有效实施提供信息。